Home/Filings/4/0001453814-19-000010
4//SEC Filing

Bergmann Rouven 4

Accession 0001453814-19-000010

CIK 0001453814other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 4:52 PM ET

Size

12.6 KB

Accession

0001453814-19-000010

Insider Transaction Report

Form 4
Period: 2019-02-12
Bergmann Rouven
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2019-02-12$71.98/sh+38,236$2,752,227114,760 total
  • Tax Payment

    Common Stock

    2019-02-12$71.36/sh17,093$1,219,75697,667 total
  • Award

    Common Stock

    2019-02-12+25,395123,062 total
  • Award

    Common Stock

    2019-02-12+7,256130,318 total
  • Award

    Restricted Stock Units (Performance-Related)

    2019-02-12+25,39525,395 total
    Exercise: $0.00Common Stock
Footnotes (5)
  • [F1]Represents restricted stock units earned in connection with a performance-based restricted stock unit ("PBRSU") award on February 26, 2016, based on achievement of certain TSR performance targets for the three years ended December 31, 2018. The restricted stock units were settled at 200% of the target grant amount. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
  • [F2]Shares withheld by Medidata to satisfy the tax withholding obligation in connection with the vesting of the PBRSU award referenced above.
  • [F3]Award of shares of restricted stock under the issuer's 2017 Long-Term Incentive Plan (the "2017 LTIP") on February 12, 2019. The restrictions will lapse with respect to one-fourth of the shares on each of February 12, 2020, February 12, 2021, February 12, 2022, and February 12, 2023.
  • [F4]Award of shares of restricted stock under the issuer's 2017 Long-Term Incentive Plan (the "2017 LTIP") on February 12, 2019. The restrictions will lapse with respect to one-half of the shares on each of February 12, 2020 and February 12, 2021.
  • [F5]Award of PBRSUs under the 2017 LTIP on February 12, 2019. The number of PBRSUs represents a target amount. Each PBRSU represents a contingent right to receive 0-225% of that target number of shares of the issuer's common stock, (i) 50% based on the issuer's TSR as compared to the TSR of companies in the Russell 2000 Index for the three years ending December 31, 2021, and (ii) 50% based on the Company's revenue attainment for the three years ending December 31, 2021. The shares will vest immediately upon being earned.

Issuer

Medidata Solutions, Inc.

CIK 0001453814

Entity typeother

Related Parties

1
  • filerCIK 0001641826

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:52 PM ET
Size
12.6 KB